Recurrent Coronary Thrombus in a Patient with Chronic Immune Thrombocytopenia with Treatment Using Eltrombopag
Case Reports in Cardiology · 26.03.2019 · 2019 · 1-5
DOI: 10.1155/2019/2756319 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Cardiology, erschienen am 26.03.2019. Verfasst von Terumori Satoh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Internal Medicine 3, Hamamatsu University School of Medicine, Hamamatsu, Japan. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
Eltrombopag, a nonpeptide thrombopoietin receptor agonist (TPO-RA), has been reported to be an effective therapy for chronic immune thrombocytopenia (ITP). However, a higher incidence of arterial and venous thromboembolic events was reported after using eltrombopag. Case Presentation . A 67-year-old man, treated with eltrombopag due to chronic ITP, was admitted due to acute coronary syndrome (ACS). Although coronary angiography revealed no occlusion, cardiac magnetic resonance imaging suggested a myocardial infarction in the territory of the left circumflex coronary artery. Three months after the ACS event, the obtuse marginal branches exhibited significant stenosis; hence, a percutaneous coronary intervention (PCI) was performed to implant a zotarolimus-eluting stent under the treatment of a dual antiplatelet therapy. However, stent thrombosis occurred 3 hours after PCI and required three other PCIs during the eltrombopag treatment.
Conclusion
We present a case of an ITP patient, who experienced repeated coronary and stent thrombosis during the treatment with eltrombopag. We propose that the risk of ACS and consequent coronary stent thrombosis should be considered before the introduction of eltrombopag.
Autor:innen und Institutionen
- Department of Cardiology, Internal Medicine 3, Hamamatsu University School of Medicine, Hamamatsu, Japan.
- Department of Hematology, Internal Medicine 3, Hamamatsu University School of Medicine, Hamamatsu, Japan.
ORCID-Profile: Masao Saotome, Yuichiro Maekawa
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Satoh, T., Saotome, M., Suwa, K., Ohtani, H., Nagata, Y., Ono, T., & Maekawa, Y. (2019). Recurrent Coronary Thrombus in a Patient with Chronic Immune Thrombocytopenia with Treatment Using Eltrombopag. Case Reports in Cardiology, 2019, 1-5. https://doi.org/10.1155/2019/2756319
Vancouver
Satoh T, Saotome M, Suwa K, Ohtani H, Nagata Y, Ono T, et al. Recurrent Coronary Thrombus in a Patient with Chronic Immune Thrombocytopenia with Treatment Using Eltrombopag. Case Reports in Cardiology. 2019;2019:1-5. doi:10.1155/2019/2756319
BibTeX
@article{Satoh2019,
author = {Satoh, Terumori and Saotome, Masao and Suwa, Kenichiro and Ohtani, Hayato and Nagata, Yasuyuki and Ono, Takaaki and Maekawa, Yuichiro},
title = {Recurrent Coronary Thrombus in a Patient with Chronic Immune Thrombocytopenia with Treatment Using Eltrombopag},
journal = {Case Reports in Cardiology},
year = {2019},
volume = {2019},
pages = {1--5},
doi = {10.1155/2019/2756319}
}
EUVIMED